NCT02768246

Brief Summary

Ventilation of a bearded patient with the commonly used face mask has low efficiency because of difficulties to achieve a tight seal around the mouth and nose. The purpose of this study is to evaluate the efficacy of a novel bag valve guedel adaptor (BVGA) that enables the direct connection of a bag valve device to a guedel - eliminating the need for a face mask.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 11, 2016

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

March 3, 2017

Status Verified

February 1, 2017

Enrollment Period

1 month

First QC Date

May 10, 2016

Last Update Submit

February 28, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • End tidal CO2 levels (EtCO2)

    EtCO2 will be monitored while the volunteer breathes through the BVGA or the face mask.

    30 minutes

Secondary Outcomes (1)

  • End tidal O2 (EtO2)

    30 minutes

Study Arms (2)

Begin with BVGA

ACTIVE COMPARATOR

The volunteers will be asked to breathe 5 minutes of room air through the BVGA, followed by, 5 minutes 100% oxygen, and 5 minutes room air again. This will be followed by 5 minutes room air breathing without the BVGA. Then the same volunteers will be asked to repeat the protocol with the face mask.

Device: BVGADevice: Face Mask

Begin with Face-mask

ACTIVE COMPARATOR

The volunteers will be asked to breathe 5 minutes of room air through the face mask, followed by, 5 minutes 100% oxygen, and 5 minutes room air again. This will be followed by 5 minutes room air breathing without the face mask. Then the same volunteers will be asked to repeat the protocol with the BVGA.

Device: BVGADevice: Face Mask

Interventions

BVGADEVICE

The BVGA enables the direct connection of a bag valve device to a guedel, eliminating the need for a face mask during ventilation

Also known as: Bag Valve Guedel Adaptor
Begin with BVGABegin with Face-mask
Face MaskDEVICE

Classic face mask

Begin with BVGABegin with Face-mask

Eligibility Criteria

Age18 Years - 65 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy males more than 18 years of age.
  • with beards, 3 without beards.

You may not qualify if:

  • Presence of facial fractures or injuries.
  • Claustrophobia.
  • Respiratory diseases.
  • Severe illness such as cardiac or neurological diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Gavish L, Rittblat M, Gertz SD, Shaylor R, Weissman C, Eisenkraft A. Ventilating the Bearded: A Randomized Crossover Trial Comparing a Novel Bag-Valve-Guedel Adaptor to a Standard Mask. Mil Med. 2020 Aug 14;185(7-8):e1300-e1308. doi: 10.1093/milmed/usz378.

MeSH Terms

Interventions

Masks

Intervention Hierarchy (Ancestors)

Surgical AttireEquipment and Supplies, HospitalEquipment and SuppliesProtective DevicesPersonal Protective EquipmentSurgical EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Ruth Shaylor, MD

    Hadassah Medical Organization

    PRINCIPAL INVESTIGATOR
  • Lilach Gavish, PhD

    Hebrew University of Jerusalem

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Director

Study Record Dates

First Submitted

May 10, 2016

First Posted

May 11, 2016

Study Start

June 1, 2016

Primary Completion

July 1, 2016

Study Completion

December 1, 2016

Last Updated

March 3, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share